Predicting and Decreasing Bladder Tumor Recurrence Following Nephroureterectomy
Hiroko Miyagi(University of Florida), Paul L. Crispen(University of Kentucky), Padraic O’Malley(University of Florida), Li‐Ming Su(UF Health Shands Hospital), Wayne Brisbane(University of California, Los Angeles), Elizabeth Di Valerio(University of Florida)
Cited by 2
Related Papers
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
|The Lancet Oncology|2020|459
An overview of kidney stone imaging techniques
|Nature Reviews Urology|2016|389
Targeted Prostate Biopsy: Umbra, Penumbra, and Value of Perilesional Sampling
|European Urology|2022|169